ArticleThoracic cancer2022

Effectiveness of alectinib and osimertinib in a brain metastasized lung adenocarcinoma patient with concurrent EGFR mutations and DCTN1-ALK fusion.

Qiang Yin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.